Macau Casino Gambli...
Affymetrix Inc. (AFFX: NASDAQ)
$4.57 -0.17 | -3.59%
06/01/12 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 4.57 |
| 52 Week High | 8.16 |
| 52 Week Low | 3.68 |
| Avg. Daily Vol. (Mil) | 0.67 |
| Beta (3 year) | 1.36 |
| Share Related Items | |
| Mkt Cap (Mil) | 321.97 |
| Shares Out (Mil) | 70.45 |
| Float (Mil) | 61.48 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 3.40 |
| Current Ratio | 4.50 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 1.24 |
| Price/Book | 1.18 |
| Price/Cash Flow | -313.00 |
| Per Share Data | |
| Earnings | -0.46 |
| Sales | 3.68 |
| Book Value | 3.87 |
| Cash Flow | -0.01 |
| Business Summary | |
|---|---|
| Affymetrix, Inc. is into develops, manufactures and sells products and services for genetic analysis to the life science research and clinical healthcare markets. | |
| General Information | |
| 3420 Central Expressway
Santa Clara, CA 95051 |
|
| www.affymetrix.com | |
| Industry : Electronics | |
| Sector: Technology | |
| Employees: 900 | |
| CEO: Dr. Frank R. Witney,,PhD | |
| Short Interest | |
| Current Month (Mil) | 6.18 |
| Previous Month (Mil) | 4.65 |
| Short Interest Ratio (Days) | 6.70 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -9.70 |
| Return on Investments | -11.00 |
| Profitability | |
| Gross Margin | 69.20 |
| EBIT Margin | -10.60 |
| Profit Margin | -12.50 |
Portfolios with AFFX
- Portfolio NameUser Type
- ContributorBreakout Stocks Of The Week...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserPART 7 JPMorgan 28th Annual...
- UserStockpickrOne
- UserLast Day of the JPMorgan He...
- ContributorFast Money's First 100 Days...
- ContributorBarron's Cheap Losers For A...
Latest AFFX Headlines from TheStreet
- Affymetrix's CEO Discusses Q1 2012 Results - Earnings Call Transcript 05.03.12 | 10:05 pm
- Affymetrix's CEO Discusses Q4 2011 Results - Earnings Call Transcript 02.08.12 | 10:02 pm
- 5 Stocks Set to Soar on Bullish Earnings 02.07.12 | 06:02 am
- Affymetrix Stock Hits New 52-Week Low (AFFX) 12.19.11 | 03:12 pm
- Affymetrix Stock Hits New 52-Week Low (AFFX) 12.09.11 | 10:12 am
- Affymetrix's CEO Discusses Q3 2011 Results - Earnings Call Transcript 11.02.11 | 08:11 pm
- ServiceSource, Illumina: After-Hours Trading 10.06.11 | 06:10 pm
- Affymetrix Inc. Stock Downgraded (AFFX) 08.05.11 | 07:08 am
- Affymetrix's CEO Discusses Q2 2011 Results - Earnings Call Transcript 07.27.11 | 11:07 pm
- 5 More Earnings Stocks Set to Soar 07.27.11 | 11:07 am
Press Releases for AFFX
- Affymetrix And Leica Microsystems Announce Worldwide Collaboration On Automated, Single-Copy, RNA In Situ Hybridization (ISH) Tissue Assay For Research Use - Business Wire 05.31.12 | 07:05 am
- Affymetrix And ScreenCell Announce Worldwide Distribution Agreement For Circulating Tumor Cell (CTC) Technology - Business Wire 05.17.12 | 07:05 am
- Affymetrix To Webcast Annual Meeting Of Shareholders - Business Wire 05.11.12 | 09:05 am
- Affymetrix And EBioscience Amend Definitive Merger Agreement - Business Wire 05.03.12 | 10:05 pm
- Affymetrix Reports First Quarter 2012 Results - Business Wire 05.03.12 | 04:05 pm
- Affymetrix To Host Conference Call On May 3, 2012 To Announce First Quarter 2012 Operating Results - Business Wire 04.17.12 | 04:04 pm
- Affymetrix Announces A Global Distribution Agreement With Almac To Distribute Its Proprietary Xcel™ Array For Translational Research Applications - Business Wire 03.29.12 | 07:03 am
- Lineagen Applies Affymetrix' GeneChip® Technology To Next-Generation FirstStepDx® Service For Individuals With Developmental Delay And Autism Spectrum Disorders - PR Newswire 03.28.12 | 07:03 am
- Affymetrix Axiom(R) Exome Genotyping Arrays (Photo: Business Wire) - Business Wire 02.23.12 | 09:02 am
- China Clears Its First Microarray Platform For In Vitro Diagnostics To Accelerate Personalized Medicine - Business Wire 02.15.12 | 06:02 pm
Partner Headlines for AFFX
- Affymetrix Inks Distribution Pact - Analyst Blog - Zacks 05.21.12 | 07:05 pm
- Benzinga's Top Upgrades with Color for May 9, 2012 - Benzinga 05.09.12 | 09:05 am
- Kinetics Hedge Fund's Top Undervalued Picks - Seeking Alpha 03.23.12 | 05:03 pm
- Zacks #5 Rank Additions for Friday - Tale of the Tape - Zacks 03.16.12 | 09:03 am
- Zacks #5 Rank Additions for Monday - Tale of the Tape - Zacks 03.12.12 | 09:03 am
- Zacks #5 Rank Additions for Thursday - Tale of the Tape - Zacks 03.08.12 | 09:03 am
- Zacks #5 Rank Additions for Tuesday - Tale of the Tape - Zacks 02.14.12 | 09:02 am
- Luminex Beats on Assay Boost - Analyst Blog - Zacks 02.07.12 | 09:02 am
- UPDATE: Deutsche Bank Upgrades Affymetrix to Buy - Benzinga 01.25.12 | 09:01 am
- Deutsche Bank Upgrades Affymetrix to Buy - Benzinga 01.25.12 | 09:01 am





